Medical Design Technology -
10 Apr 2017 20:07
News The new test makes use of a "synthetic biomarker" -- a nanoparticle that interacts with tumor proteins to release fragments ... Contributed Author: Anne Trafton, Massachusetts Institute of Technology Topics: Oncology
Share this Article